CNSX:SPR

Spirit AeroSystems Competitors

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume199,545 shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Spirit AeroSystems (CNSX:SPR) Vs. RIV, WLLW, LABS, KHRN, DN, and META

Should you be buying SPR stock or one of its competitors? Companies in the industry of "drug manufacturers—specialty & generic" are considered alternatives and competitors to Spirit AeroSystems, including RIV Capital (RIV), Willow Biosciences Inc. (WLLW.TO) (WLLW), MediPharm Labs (LABS), Khiron Life Sciences (KHRN), Delta 9 Cannabis (DN), and Meta Growth (META).

Spirit AeroSystems vs. RIV Capital Stock

RIV Capital (TSE:RIV) and Spirit AeroSystems (CNSX:SPR) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, analyst recommendations, dividends and earnings.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for RIV Capital and Spirit AeroSystems, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RIV Capital	0	1	0	0	2.00
Spirit AeroSystems	0	0	0	0	N/A

RIV Capital currently has a consensus target price of C$4.00, indicating a potential upside of 107.25%.

Profitability

This table compares RIV Capital and Spirit AeroSystems' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
RIV Capital	N/A	N/A	N/A
Spirit AeroSystems	N/A	N/A	N/A

Earnings & Valuation

This table compares RIV Capital and Spirit AeroSystems' gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RIV Capital	C$15.44 million	17.49	$-106,223,568.00	C($0.76)	-2.54
Spirit AeroSystems	N/A	N/A	N/A	N/A	N/A

Spirit AeroSystems has lower revenue, but higher earnings than RIV Capital.

Summary

RIV Capital beats Spirit AeroSystems on 1 of the 1 factors compared between the two stocks.

Spirit AeroSystems vs. Willow Biosciences Inc. (WLLW.TO) Stock

Willow Biosciences Inc. (WLLW.TO) (TSE:WLLW) and Spirit AeroSystems (CNSX:SPR) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, valuation, risk, institutional ownership, profitability and dividends.

Profitability

This table compares Willow Biosciences Inc. (WLLW.TO) and Spirit AeroSystems' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Willow Biosciences Inc. (WLLW.TO)	N/A	N/A	N/A
Spirit AeroSystems	N/A	N/A	N/A

Earnings and Valuation

This table compares Willow Biosciences Inc. (WLLW.TO) and Spirit AeroSystems' revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Willow Biosciences Inc. (WLLW.TO)	C$10,000.00	15,531.77	$-51,032,952.00	C($0.41)	-3.04
Spirit AeroSystems	N/A	N/A	N/A	N/A	N/A

Spirit AeroSystems has lower revenue, but higher earnings than Willow Biosciences Inc. (WLLW.TO).

Analyst Recommendations

This is a breakdown of recent recommendations for Willow Biosciences Inc. (WLLW.TO) and Spirit AeroSystems, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Willow Biosciences Inc. (WLLW.TO)	0	0	0	0	N/A
Spirit AeroSystems	0	0	0	0	N/A

Willow Biosciences Inc. (WLLW.TO) currently has a consensus price target of C$2.25, suggesting a potential upside of 78.57%.

Summary

Willow Biosciences Inc. (WLLW.TO) beats Spirit AeroSystems on 1 of the 1 factors compared between the two stocks.

Spirit AeroSystems vs. MediPharm Labs Stock

MediPharm Labs (TSE:LABS) and Spirit AeroSystems (CNSX:SPR) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, risk, profitability, earnings and institutional ownership.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for MediPharm Labs and Spirit AeroSystems, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MediPharm Labs	0	2	0	2	3.00
Spirit AeroSystems	0	0	0	0	N/A

MediPharm Labs presently has a consensus target price of C$1.53, suggesting a potential upside of 225.53%.

Profitability

This table compares MediPharm Labs and Spirit AeroSystems' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
MediPharm Labs	N/A	N/A	N/A
Spirit AeroSystems	N/A	N/A	N/A

Earnings & Valuation

This table compares MediPharm Labs and Spirit AeroSystems' revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MediPharm Labs	C$36.01 million	3.37	$-123,815,040.00	C($0.48)	-0.98
Spirit AeroSystems	N/A	N/A	N/A	N/A	N/A

Spirit AeroSystems has lower revenue, but higher earnings than MediPharm Labs.

Summary

MediPharm Labs beats Spirit AeroSystems on 2 of the 2 factors compared between the two stocks.

Spirit AeroSystems vs. Khiron Life Sciences Stock

Khiron Life Sciences (CVE:KHRN) and Spirit AeroSystems (CNSX:SPR) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, institutional ownership, risk, valuation and dividends.

Profitability

This table compares Khiron Life Sciences and Spirit AeroSystems' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Khiron Life Sciences	N/A	N/A	N/A
Spirit AeroSystems	N/A	N/A	N/A

Analyst Ratings

This is a summary of current recommendations and price targets for Khiron Life Sciences and Spirit AeroSystems, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Khiron Life Sciences	0	0	0	0	N/A
Spirit AeroSystems	0	0	0	0	N/A

Khiron Life Sciences presently has a consensus price target of C$1.20, indicating a potential upside of 155.32%.

Earnings and Valuation

This table compares Khiron Life Sciences and Spirit AeroSystems' revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Khiron Life Sciences	C$8.01 million	8.81	$-39,493,921.00	C($0.26)	-1.79
Spirit AeroSystems	N/A	N/A	N/A	N/A	N/A

Spirit AeroSystems has lower revenue, but higher earnings than Khiron Life Sciences.

Summary

Khiron Life Sciences beats Spirit AeroSystems on 1 of the 1 factors compared between the two stocks.

Spirit AeroSystems vs. Delta 9 Cannabis Stock

Delta 9 Cannabis (TSE:DN) and Spirit AeroSystems (CNSX:SPR) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, earnings, profitability, analyst recommendations, institutional ownership, valuation and dividends.

Valuation and Earnings

This table compares Delta 9 Cannabis and Spirit AeroSystems' gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Delta 9 Cannabis	C$52.05 million	1.12	$-7,346,808.00	C($0.07)	-7.92
Spirit AeroSystems	N/A	N/A	N/A	N/A	N/A

Spirit AeroSystems has lower revenue, but higher earnings than Delta 9 Cannabis.

Profitability

This table compares Delta 9 Cannabis and Spirit AeroSystems' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Delta 9 Cannabis	N/A	N/A	N/A
Spirit AeroSystems	N/A	N/A	N/A

Analyst Ratings

This is a summary of recent ratings and price targets for Delta 9 Cannabis and Spirit AeroSystems, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Delta 9 Cannabis	0	0	0	1	4.00
Spirit AeroSystems	0	0	0	0	N/A

Delta 9 Cannabis presently has a consensus target price of C$1.10, suggesting a potential upside of 92.98%.

Summary

Delta 9 Cannabis beats Spirit AeroSystems on 2 of the 2 factors compared between the two stocks.

Spirit AeroSystems vs. Meta Growth Stock

Meta Growth (CVE:META) and Spirit AeroSystems (CNSX:SPR) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, risk, profitability, analyst recommendations and earnings.

Earnings and Valuation

This table compares Meta Growth and Spirit AeroSystems' revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Meta Growth	C$60.96 million	0.54	$-50,412,840.00	C($0.21)	-0.66
Spirit AeroSystems	N/A	N/A	N/A	N/A	N/A

Spirit AeroSystems has lower revenue, but higher earnings than Meta Growth.

Analyst Ratings

This is a summary of recent ratings and target prices for Meta Growth and Spirit AeroSystems, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Meta Growth	0	0	0	0	N/A
Spirit AeroSystems	0	0	0	0	N/A

Profitability

This table compares Meta Growth and Spirit AeroSystems' net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Meta Growth	N/A	N/A	N/A
Spirit AeroSystems	N/A	N/A	N/A

Summary

Meta Growth beats Spirit AeroSystems on 1 of the 1 factors compared between the two stocks.